SAB Biotherapeutics, Inc. Common Stock (SABS) Stock Price
SAB Biotherapeutics, Inc. Common Stock (NASDAQ: SABS) last traded at $3.78, up 2.16% on the session. The quote above updates while this page is open; the figures below are drawn from SAB Biotherapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
SAB Biotherapeutics, Inc. Common Stock (SABS) company overview
SAB Biotherapeutics, Inc. Common Stock trades on NASDAQ under the ticker SABS. Its market capitalisation is $343.93 million.
SABS valuation
Valuation measures for SAB Biotherapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
Market cap
$343.93M
Enterprise value
$359.09M
Price / book
1.60
Beta
1.23
SABS financials
Trailing-twelve-month figures tagged in SAB Biotherapeutics, Inc. Common Stock's XBRL filings with the SEC.
Revenue (TTM)
$0.00
Net income (TTM)
-$12.78M
Return on equity
-5.95%
Cash
$8.27M
SABS trading statistics
Range and volume for SABS over the past 52 weeks.
52-week high
$5.15
52-week low
$1.85
Volume
194.5K
Average volume
669.1K
Previous close
$3.70
SAB Biotherapeutics, Inc. Common Stock (SABS) FAQs
What is the SABS stock price today?
SAB Biotherapeutics, Inc. Common Stock (SABS) last traded at $3.78, up 2.16% on the session. FurlPay quotes SABS from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is SABS listed on?
SAB Biotherapeutics, Inc. Common Stock is listed on NASDAQ under the ticker symbol SABS.
What is SAB Biotherapeutics, Inc. Common Stock's market cap?
SAB Biotherapeutics, Inc. Common Stock has a market capitalisation of $343.93 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is SABS's 52-week range?
Over the past 52 weeks SABS has traded between $1.85 and $5.15.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001833214), period ending 2025-12-31.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.
SABS Stock Price & Quote | SAB Biotherapeutics, Inc. Common Stock | FurlPay